| UniProt ID | NADE_HUMAN | |
|---|---|---|
| UniProt AC | Q6IA69 | |
| Protein Name | Glutamine-dependent NAD(+) synthetase | |
| Gene Name | NADSYN1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 706 | |
| Subcellular Localization | ||
| Protein Description | ||
| Protein Sequence | MGRKVTVATCALNQWALDFEGNLQRILKSIEIAKNRGARYRLGPELEICGYGCWDHYYESDTLLHSFQVLAALVESPVTQDIICDVGMPVMHRNVRYNCRVIFLNRKILLIRPKMALANEGNYRELRWFTPWSRSRHTEEYFLPRMIQDLTKQETVPFGDAVLVTWDTCIGSEICEELWTPHSPHIDMGLDGVEIITNASGSHQVLRKANTRVDLVTMVTSKNGGIYLLANQKGCDGDRLYYDGCAMIAMNGSVFAQGSQFSLDDVEVLTATLDLEDVRSYRAEISSRNLAASRASPYPRVKVDFALSCHEDLLAPISEPIEWKYHSPEEEISLGPACWLWDFLRRSQQAGFLLPLSGGVDSAATACLIYSMCCQVCEAVRSGNEEVLADVRTIVNQISYTPQDPRDLCGRILTTCYMASKNSSQETCTRARELAQQIGSHHISLNIDPAVKAVMGIFSLVTGKSPLFAAHGGSSRENLALQNVQARIRMVLAYLFAQLSLWSRGVHGGLLVLGSANVDESLLGYLTKYDCSSADINPIGGISKTDLRAFVQFCIQRFQLPALQSILLAPATAELEPLADGQVSQTDEEDMGMTYAELSVYGKLRKVAKMGPYSMFCKLLGMWRHICTPRQVADKVKRFFSKYSMNRHKMTTLTPAYHAENYSPEDNRFDLRPFLYNTSWPWQFRCIENQVLQLERAEPQSLDGVD | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 4 (in isoform 2) | Phosphorylation | - | 36.21 | 29507054 | |
| 12 (in isoform 2) | Phosphorylation | - | 5.49 | 29507054 | |
| 20 (in isoform 2) | Phosphorylation | - | 47.00 | 29507054 | |
| 21 (in isoform 2) | Phosphorylation | - | 39.89 | 29116813 | |
| 28 | Ubiquitination | GNLQRILKSIEIAKN CHHHHHHHHHHHHHH | 47.19 | 29901268 | |
| 29 | Phosphorylation | NLQRILKSIEIAKNR HHHHHHHHHHHHHHC | 23.24 | 22496350 | |
| 34 | Ubiquitination | LKSIEIAKNRGARYR HHHHHHHHHCCCCCC | 53.49 | 27667366 | |
| 161 | Ubiquitination | ETVPFGDAVLVTWDT CCCCCCCEEEEEECC | 9.27 | - | |
| 211 | Phosphorylation | QVLRKANTRVDLVTM HHHHHCCCCEEEEEE | 36.61 | 29978859 | |
| 217 | Phosphorylation | NTRVDLVTMVTSKNG CCCEEEEEEEECCCC | 17.14 | 29978859 | |
| 218 | Sulfoxidation | TRVDLVTMVTSKNGG CCEEEEEEEECCCCC | 2.11 | 21406390 | |
| 220 | Phosphorylation | VDLVTMVTSKNGGIY EEEEEEEECCCCCEE | 24.14 | 29978859 | |
| 221 | Phosphorylation | DLVTMVTSKNGGIYL EEEEEEECCCCCEEE | 16.83 | 29978859 | |
| 227 | Phosphorylation | TSKNGGIYLLANQKG ECCCCCEEEEECCCC | 10.03 | 29978859 | |
| 382 | Ubiquitination | QVCEAVRSGNEEVLA HHHHHHHCCCHHHHH | 39.10 | - | |
| 389 | Ubiquitination | SGNEEVLADVRTIVN CCCHHHHHHHHHHHH | 20.59 | - | |
| 421 | Ubiquitination | TTCYMASKNSSQETC HHHHHHCCCCCHHHH | 51.84 | 22505724 | |
| 423 | Phosphorylation | CYMASKNSSQETCTR HHHHCCCCCHHHHHH | 36.82 | - | |
| 424 | Phosphorylation | YMASKNSSQETCTRA HHHCCCCCHHHHHHH | 41.24 | - | |
| 427 | Phosphorylation | SKNSSQETCTRAREL CCCCCHHHHHHHHHH | 16.13 | - | |
| 429 | Phosphorylation | NSSQETCTRARELAQ CCCHHHHHHHHHHHH | 34.48 | - | |
| 462 | Phosphorylation | MGIFSLVTGKSPLFA HHHHHHHHCCCCCHH | 44.15 | - | |
| 500 | Phosphorylation | AYLFAQLSLWSRGVH HHHHHHHHHHHCCCC | 18.73 | 28122231 | |
| 503 | Phosphorylation | FAQLSLWSRGVHGGL HHHHHHHHCCCCCCE | 25.17 | 28122231 | |
| 521 | Phosphorylation | GSANVDESLLGYLTK CCCCCCHHHHHHHHH | 25.16 | 24719451 | |
| 532 | Phosphorylation | YLTKYDCSSADINPI HHHHCCCCCCCCCCC | 26.18 | 30631047 | |
| 533 | Phosphorylation | LTKYDCSSADINPIG HHHCCCCCCCCCCCC | 35.97 | 30631047 | |
| 544 | Ubiquitination | NPIGGISKTDLRAFV CCCCCCCHHHHHHHH | 44.10 | 33845483 | |
| 637 | Ubiquitination | RQVADKVKRFFSKYS HHHHHHHHHHHHHHC | 49.59 | 23000965 | |
| 641 | Phosphorylation | DKVKRFFSKYSMNRH HHHHHHHHHHCCCCC | 28.15 | 23532336 | |
| 642 | Ubiquitination | KVKRFFSKYSMNRHK HHHHHHHHHCCCCCC | 35.87 | 21890473 | |
| 642 | Ubiquitination | KVKRFFSKYSMNRHK HHHHHHHHHCCCCCC | 35.87 | 23000965 | |
| 643 | Phosphorylation | VKRFFSKYSMNRHKM HHHHHHHHCCCCCCC | 16.38 | - | |
| 644 | Phosphorylation | KRFFSKYSMNRHKMT HHHHHHHCCCCCCCC | 17.20 | - | |
| 649 | Ubiquitination | KYSMNRHKMTTLTPA HHCCCCCCCCCCCCC | 34.40 | 21963094 | |
| 649 | Ubiquitination | KYSMNRHKMTTLTPA HHCCCCCCCCCCCCC | 34.40 | 21890473 | |
| 657 | Phosphorylation | MTTLTPAYHAENYSP CCCCCCCCCCCCCCC | 11.63 | - | |
| 701 | Phosphorylation | LERAEPQSLDGVD-- HHHCCCCCCCCCC-- | 38.86 | 24719451 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NADE_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NADE_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NADE_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|
| Kegg Disease | |
|---|---|
| There are no disease associations of PTM sites. | |
| OMIM Disease | |
| There are no disease associations of PTM sites. | |
| Kegg Drug | |
| There are no disease associations of PTM sites. | |
| DrugBank | |
| DB00130 | L-Glutamine |
loading...